首页> 外文期刊>BMC Cardiovascular Disorders >The preablation monocyte/ high density lipoprotein ratio predicts the late recurrence of paroxysmal atrial fibrillation after radiofrequency ablation
【24h】

The preablation monocyte/ high density lipoprotein ratio predicts the late recurrence of paroxysmal atrial fibrillation after radiofrequency ablation

机译:射频烧蚀后,术后单核细胞/高密度脂蛋白比率预测阵发性心房颤动的后期复发

获取原文
           

摘要

The monocyte/high-density lipoprotein ratio (MHR) has emerged as a promising alternative biomarker in the fields of cardiovascular disease and atrial fibrillation (AF). This retrospective study was aimed to explore the predictive value of the MHR for the late recurrence of AF after radiofrequency ablation. From April 2015 to October 2018, patients with paroxysmal AF who had undergone radiofrequency catheter ablation at Subei People’s Hospital of Jiangsu Province were enrolled in our study. All the participants were observed until November 2019 after the procedure. During the postoperative follow up, the patients were categorized into the recurrence group and maintenance of sinus rhythm group based on who had experienced AF recurrence. One hundred twenty-five patients were diagnosed with paroxysmal AF, with an average age of 61.2?±?9.3?years. Forty-seven patients had developed late recurrence during a mean follow up of 25.1?±?12.0?months. The AF recurrence event rates were significantly increased in the highest MHR tertile compared with those in the lowest MHR tertile (22.0% vs. 57.1%; P??0.05). On multivariate logistic regression analysis, the preablation MHR (OR?=?1.34; 95% CI?=?1.12?~?1.60; P?=?0.001) and left atrial diameter (LAD) (OR?=?1.21, 95% CI?=?1.08?~?1.35; P?=?0.001) were independent risk factors predicting the recurrence of AF after radiofrequency ablation. Furthermore, receiver operating characteristic (ROC) curve analysis revealed that the area under the curve (AUC) of the MHR was 0.712 (95% CI?=?0.618?~?0.806; P?=?0.000) and that of LAD was 0.739 (95% CI?=?0.653?~?0.814; P?=?0.000). Z-test found no significant difference between the MHR and LAD regarding the AUC (Z?=?0.451; P?=?0.652). An elevated preablation MHR was associated with an increased risk of the postoperative recurrence of AF. Additionally, the MHR independently predicted the late recurrence of paroxysmal AF after radiofrequency ablation, with the same predictive value as LAD.
机译:单核细胞/高密度脂蛋白比率(MHR)在心血管疾病和心房颤动(AF)的田地中是一种有前途的替代生物标志物。这种回顾性研究旨在探讨MHR的预测值,以便在射频消融后的AF后复发。从2015年4月到2018年10月,在江苏省亚洲人民医院患有辐射导管消融的阵发性患者均已注册我们的研究。所有参与者都被观察到2019年11月。在术后随访期间,患者被分为复发群体和基于谁经历过的AF复发的窦性心律组的维持。一百二十五名患者被诊断出患有阵发性AF,平均年龄为61.2?±9.3?年。 47名患者在25.1±12.0?月份的平均随访期间开发了晚期复发。与最低MHR Tertile中的最高MHR Tertile相比,AF复发事件率在最高的MHR Tertile中显着增加(22.0%与57.1%; p?<0.05)。在多变量逻辑回归分析中,序列MHR(或?=?1.34; 95%CI?=?1.12?〜1.60; P?= 0.001)和左心房直径(或者?=?1.21,95% CI?=?1.08?〜?1.35; p?= 0.001)是预测射频消融后AF复发的独立风险因素。此外,接收器操作特征(ROC)曲线分析显示MHR的曲线(AUC)下的面积为0.712(95%CI?= 0.618?0.806; p?=?0.000)和Lad为0.739 (95%CI?=?0.653?〜?0.814; p?= 0.000)。 Z检验发现,MHR和LAD之间没有关于AUC(Z?= 0.451; P?= 0.652)的显着差异。升高的序列MHR与AF术后复发的风险增加有关。另外,MHR独立地预测了辐射释放后阵发性AF的后期复发,具有与LAD相同的预测值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号